Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study)
Authors:
Open Access
- 7 July 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1550636
Abstract
Background: Significant clinical similarities have been observed between the recently described “Long-Haul” COVID-19 (LHC) syndrome, Postural Orthostatic Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST). Shared symptoms include light-headedness, palpitations, tremulousness, generalized weakness, blurred vision, chest pain, dyspnea, “brain-fog,” and fatigue. Ivabradine is a selective sinoatrial node blocker FDA-approved for management of tachycardia associated with stable angina and heart failure not fully managed by beta blockers. In our study we aim to identify risk factors underlying LHC, as well as the effectiveness of ivabradine in controlling heart rate dysregulations and POTS/IST related symptoms.Methods/design: A detailed prospective phenotypic evaluation combined with multi-omic analysis of 200 LHC volunteers will be conducted to identify risk factors for autonomic dysfunction. A comparator group of 50 volunteers with documented COVID-19 but without LHC will be enrolled to better understand the risk factors for LHC and autonomic dysfunction. Those in the cohort who meet diagnostic criteria for POTS or IST will be included in a nested prospective, randomized, placebo-controlled trial to assess the impact of ivabradine on symptoms and heart rate, assessed non-invasively based on physiologic response and ambulatory electrocardiogram. Additionally, studies on catecholamine production, mast cell and basophil degranulation, inflammatory biomarkers, and indicators of metabolic dysfunction will be measured to potentially provide molecular classification and mechanistic insights.Discussion: Optimal therapies for dysautonomia, particularly associated with LHC, have yet to be defined. In the present study, ivabradine, one of numerous proposed interventions, will be systematically evaluated for therapeutic potential in LHC-associated POTS and IST. Additionally, this study will further refine the characteristics of the LHC-associated POTS/IST phenotype, genotype and transcriptional profile, including immunologic and multi-omic analysis of persistent immune activation and dysregulation. The study will also explore and identify potential endotheliopathy and abnormalities of the clotting cascade.Clinical trial registration: https://clinicaltrials.gov/, identifier NCT05481177.Keywords
All Related Versions
This publication has 58 references indexed in Scilit:
- Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severityGene, 2022
- Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID‐19 severity: A systematic review with meta‐analysisReviews in Medical Virology, 2022
- Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 SyndromeThe American Journal of Medicine, 2021
- A role for T‐cell exhaustion in Long COVID‐19 and severe outcomes for several categories of COVID‐19 patientsJournal of Neuroscience Research, 2021
- Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?American Heart Journal Plus: Cardiology Research and Practice, 2021
- Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patientsImmunologic Research, 2021
- Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”Annals of Clinical and Translational Neurology, 2021
- Long-COVID postural tachycardia syndrome: an American Autonomic Society statementClinical Autonomic Research, 2021
- COVID-19-associated coagulopathy and disseminated intravascular coagulationInternational Journal of Hematology, 2020
- Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic IntoleranceCanadian Journal of Cardiology, 2020